ATE334697T1 - Boviner atmungs- und darmcoronavirus als impfstoff - Google Patents

Boviner atmungs- und darmcoronavirus als impfstoff

Info

Publication number
ATE334697T1
ATE334697T1 AT98907727T AT98907727T ATE334697T1 AT E334697 T1 ATE334697 T1 AT E334697T1 AT 98907727 T AT98907727 T AT 98907727T AT 98907727 T AT98907727 T AT 98907727T AT E334697 T1 ATE334697 T1 AT E334697T1
Authority
AT
Austria
Prior art keywords
coronavirus
vaccine
bovine respiratory
intestine
bovine
Prior art date
Application number
AT98907727T
Other languages
English (en)
Inventor
Lisa C Stine
Michael J Mcginley
Gary A Anderson
Douglas L Stine
Karen K Brown
Andre D Dory
Adrian Liem
Original Assignee
Bayer Corp
Immtech Biolog Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp, Immtech Biolog Llc filed Critical Bayer Corp
Application granted granted Critical
Publication of ATE334697T1 publication Critical patent/ATE334697T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98907727T 1997-03-10 1998-03-04 Boviner atmungs- und darmcoronavirus als impfstoff ATE334697T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81431197A 1997-03-10 1997-03-10

Publications (1)

Publication Number Publication Date
ATE334697T1 true ATE334697T1 (de) 2006-08-15

Family

ID=25214684

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907727T ATE334697T1 (de) 1997-03-10 1998-03-04 Boviner atmungs- und darmcoronavirus als impfstoff

Country Status (13)

Country Link
EP (1) EP0975360B1 (de)
JP (1) JP2001519781A (de)
KR (1) KR100531491B1 (de)
CN (1) CN1283315C (de)
AT (1) ATE334697T1 (de)
AU (1) AU725439B2 (de)
BR (1) BR9808226A (de)
CA (1) CA2231591A1 (de)
DE (1) DE69835424T2 (de)
DK (1) DK0975360T3 (de)
ES (1) ES2270508T3 (de)
NZ (1) NZ337702A (de)
WO (1) WO1998040097A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
JP2005508945A (ja) * 2001-10-06 2005-04-07 メリアル リミテッド Cpg配合物及び関連方法
CN1768074B (zh) * 2003-03-24 2010-04-28 港大科桥有限公司 对引起严重急性呼吸道综合症(sars)的人病毒的诊断性试验
WO2004085633A1 (en) * 2003-03-24 2004-10-07 The University Of Hong Kong A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
EP1649053A4 (de) * 2003-06-18 2006-10-18 Chinese Nat Human Genome Ct Sh Charakterisierung der frühesten stufen des virus des schweren akuten respiratorischen syndroms (sars) und verwendungen davon
CN1318580C (zh) * 2003-07-10 2007-05-30 北京科兴生物制品有限公司 可满足灭活疫苗生产的sars病毒规模化制备及灭活的方法
WO2011056175A1 (en) 2009-11-06 2011-05-12 Intervet International B.V. Methods of immunizing pregnant heifers at three months of gestation
WO2016034610A1 (en) * 2014-09-03 2016-03-10 Intervet International B.V. Attenuated bovine coronavirus and related vaccines
CN111117975A (zh) * 2020-01-03 2020-05-08 西南民族大学 牛冠状病毒he基因重组株及其制备的灭活疫苗和应用
CN113322241B (zh) * 2021-05-14 2023-06-13 金宇保灵生物药品有限公司 一种牛副流感病毒3型病毒株bpiv3-nm及其应用
CN117286111B (zh) * 2023-03-13 2024-06-18 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 牛冠状病毒分离株、稳定表达牛冠状病毒n蛋白细胞系及在构建反向遗传操作系统中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580778A (en) * 1994-06-15 1996-12-03 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isolation and diagnosis of coronaviruses as a factor in bovine shipping fever, and a cell line for culturing both those and other bovine coronaviruses
CA2224309C (en) * 1995-06-12 2011-01-25 Kansas State University Research Foundation Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection

Also Published As

Publication number Publication date
KR20000075775A (ko) 2000-12-26
NZ337702A (en) 2001-05-25
CN1250380A (zh) 2000-04-12
CN1283315C (zh) 2006-11-08
DK0975360T3 (da) 2006-11-27
EP0975360B1 (de) 2006-08-02
AU6346598A (en) 1998-09-29
JP2001519781A (ja) 2001-10-23
KR100531491B1 (ko) 2005-11-28
BR9808226A (pt) 2000-05-16
CA2231591A1 (en) 1998-09-10
ES2270508T3 (es) 2007-04-01
DE69835424D1 (de) 2006-09-14
AU725439B2 (en) 2000-10-12
WO1998040097A3 (en) 1999-01-14
WO1998040097A2 (en) 1998-09-17
DE69835424T2 (de) 2007-02-08
EP0975360A2 (de) 2000-02-02

Similar Documents

Publication Publication Date Title
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
ATE264691T1 (de) Newcastle-krankheitsvirus-kombinationsimpfstoff
NO991524L (no) Vaksiner
NO982497D0 (no) Vaksine-sammensetninger for inntak gjennom nesen
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
CY1107550T1 (el) Συνδυαστικα εμβολια μηνιγγιτιδας b/c
DE69837209D1 (de) Zusammensetzungen und methoden zur systemischen verabreichung von oralen impfstoffen und therapeutischen wirkstoffen
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
DE60125797D1 (de) Impfstoffzusammesetzung
ATE425253T1 (de) Tribonektine
AU7814498A (en) Multivalent (in ovo) avian vaccine
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
ATE334697T1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
AU2001258373A1 (en) Method for identifying helicobacter antigens
HU0000362D0 (en) Novel antigenic class of avian reoviruses
DE69738641D1 (de) Lebend-impfstoff gegen heliobacter pylori
HUP9801572A2 (hu) Chlamydia-vakcinák
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
DK1141305T3 (da) Kimært gen som koder for de antigene determinanter af fire proteiner af L. infantum
ATE283066T1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
WO1999020305A8 (en) Veterinary vaccines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975360

Country of ref document: EP

REN Ceased due to non-payment of the annual fee